Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.3NOK
45.60 MNOK
435.39 MNOK
19.57 M
About VISTIN PHARMA ASA
Sector
CEO
Magnus Tolleshaug
Headquarters
Oslo
Website
Employees (FY)
77
Founded
2015
ISIN
NO0010734122
FIGI
BBG00N0NSM63
Vistin Pharma ASA engages in the manufacture and sale of metformin products. It offers Metformin HCI and Metformin DC. It operates through the following segments: Pharmaceuticals, Energy Trading, and Headquarter and Other. The company was founded on March 6, 2015 and is headquartered in Oslo, Norway.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0RAM is 24.3 NOK — it has increased by 1.67% in the past 24 hours. Watch VISTIN PHARMA ASA NOK1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange VISTIN PHARMA ASA NOK1 stocks are traded under the ticker 0RAM.
0RAM reached its all-time high on Apr 22, 2021 with the price of 27.0 NOK, and its all-time low was 10.4 NOK and was reached on Feb 7, 2018. View more price dynamics on 0RAM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0RAM stock is 1.65% volatile and has beta coefficient of 0.51. Track VISTIN PHARMA ASA NOK1 stock price on the chart and check out the list of the most volatile stocks — is VISTIN PHARMA ASA NOK1 there?
Today VISTIN PHARMA ASA NOK1 has the market capitalization of 1.00 B, it has increased by 2.53% over the last week.
Yes, you can track VISTIN PHARMA ASA NOK1 financials in yearly and quarterly reports right on TradingView.
VISTIN PHARMA ASA NOK1 is going to release the next earnings report on Aug 23, 2024. Keep track of upcoming events with our Earnings Calendar.
0RAM net income for the last quarter is 7.66 M NOK, while the quarter before that showed 18.03 M NOK of net income which accounts for −57.55% change. Track more VISTIN PHARMA ASA NOK1 financial stats to get the full picture.
As of Jun 5, 2024, the company has 77.00 employees. See our rating of the largest employees — is VISTIN PHARMA ASA NOK1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VISTIN PHARMA ASA NOK1 EBITDA is 92.24 M NOK, and current EBITDA margin is 19.06%. See more stats in VISTIN PHARMA ASA NOK1 financial statements.
Like other stocks, 0RAM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VISTIN PHARMA ASA NOK1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VISTIN PHARMA ASA NOK1 technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VISTIN PHARMA ASA NOK1 stock shows the buy signal. See more of VISTIN PHARMA ASA NOK1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.